News and Trends 17 Dec 2019 Update: Cell Therapy Biotech Raises €47M to Fund NASH Clinical Trial Update (17/12/2019): Promethera has increased the total raised in its Series D round to €47.2M with the addition of new investors, including Innovation Growth Ventures and Pegasus Tech Ventures among others. The round will fund two ongoing clinical trials and the start of at least two new trials outside Europe. Published on 07/05/2019 The Belgian […] December 17, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 16 Dec 2019 Amarin’s Triglyceride-Lowering Drug Gets Second FDA Nod to Tackle Cardiovascular Disease A treatment developed by the Irish company Amarin has become the first FDA-approved drug to lower the risk of strokes and heart attacks when combined with statins in patients with high levels of circulating fat molecules called triglycerides. To be eligible for Vascepa, patients must also either have established cardiovascular disease, or type 2 diabetes […] December 16, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Best in Biotech 16 Dec 2019 10 Holiday Gifts for the Biotechnologist in Your Life Socks and sweaters are great gifts for Christmas, but sometimes, a bit of biotech love goes a long way. Here’s a list of cool holiday gifts to get for your biotech friends and family. Whether it’s a fancy genetics shoulder bag, a cuddly immune cell, or glow-in-the-dark mushrooms, you have this holiday sorted. DNA-shaped […] December 16, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 13 Dec 2019 Transgene’s Cancer Vaccine Abandoned after Phase II Fail French biotech Transgene has ceased the development of a therapeutic cancer vaccine that failed to shrink tumors in patients with lung cancer in a phase II trial. In the phase II trial, Transgene tested its therapeutic cancer vaccine in combination with chemotherapy and the checkpoint inhibitor drug nivolumab, marketed as Opdivo. The treatment failed to […] December 13, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 12 Dec 2019 Iterum Therapeutics Reels from Antibiotic Phase III Fail An antibiotic candidate developed by the Irish company Iterum Therapeutics has failed to meet the main goal of a phase III trial, a blow for efforts to meet the challenge of global antibiotic resistance. Iterum Therapeutics’ drug sulopenem was tested in a phase III trial that recruited 674 patients suffering from complicated intra-abdominal infections. These […] December 12, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Expert Advice 12 Dec 2019 Tips & Tricks for Social Media in the Life Sciences With social media, as with many industries, you have to make sure to stay on top of the game. The phrase ‘if you snooze, you lose’ remains as true as ever. If you don’t jump on the bandwagon now, you might be in for a bad surprise later. We don’t want you to miss out, […] December 12, 2019 - 14 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
Expert Advice 11 Dec 2019 What Makes a Successful Biotech? How does it feel to have co-developed the most successful drug in the world? This is something Jane Osbourn, now Chair of the Board at UK cell therapy biotech Mogrify, knows only too well. Early in her career, Osbourn was working as a postdoc in Cambridge and was persuaded to join a small, and at […] December 11, 2019 - 12 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 11 Dec 2019 €14M Series A to Fund Cancer Immunotherapy Boosting Checkpoint Inhibitors The Swiss biotech ImmunOs Therapeutics has raised a Series A round of €13.7M (CHF 15M) that will fund the first human trials of its cancer immunotherapy that could improve the response of cancer patients to checkpoint inhibitors. The round was co-led by the Swiss life sciences venture capital firm BioMedPartners and by Pfizer Ventures. The […] December 11, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Interview 11 Dec 2019 Collaboration Between Founders and Investors Primes Biotech Startups for Success How can entrepreneurs work with investors to maximize the chances of their company succeeding? Venture capital partner Nanna Lüneborg and biotech entrepreneur Mai-Britt Zocca spoke at Labiotech Refresh in Copenhagen about their experiences in founding IO Biotech, a Danish biotech startup that develops cancer immunotherapies. Zocca and Lüneborg were both involved in setting up IO […] December 11, 2019 - 5 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
More News! 10 Dec 2019 After Phase III Failure, UK Firm Pushes Placebo to Treat Erectile Dysfunction The strong placebo effect seen in Futura Medical’s phase III trial in erectile dysfunction has not deterred the company, but has instead encouraged it to seek approval for its medical device delivering the placebo rather than the drug as originally intended. Based in Surrey, UK, Futura Medical is developing a medical device used […] December 10, 2019 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
More News! 10 Dec 2019 ObsEva’s Oral Treatment for Uterine Fibroids Nails Phase III An oral drug developed by the Swiss company ObsEva was shown to reduce menstrual bleeding and pain caused by uterine fibroids. The phase III trial tested ObsEva’s drug candidate linzagolix in 535 women suffering from heavy menstrual bleeding caused by benign tumors in the uterus called uterine fibroids. The effects of the drug were compared […] December 10, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 9 Dec 2019 Autolus Reveals Early Clinical Data of Next-Gen CAR-T Therapy London-based Autolus has shown its next-generation CAR T-cell therapy does not induce some of the severe side effects that have led to deaths in patients treated with CAR T-cell treatments currently on the market. Since their arrival on the market in 2017, CAR T-cell therapies have provided hope to patients with rare forms of blood […] December 9, 2019 - 4 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email